The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Med.
Sec. Hepatobiliary Diseases
Volume 12 - 2025 |
doi: 10.3389/fmed.2025.1528733
This article is part of the Research Topic Chronic Hepatitis B Management: Current Status and Future Directions View all 13 articles
Inflammatory lipid biomarkers and transplant-free mortality risk in hepatitis B-related cirrhosis and hepatic encephalopathy
Provisionally accepted- Beijing Ditan Hospital, Capital Medical University, Beijing, China
Objective: Inflammatory reactions and dyslipidemia are associated with the pathogenesis and prognosis of hepatitis B virus-related cirrhosis. We aimed to assess the predictive ability of these parameters in patients with hepatitis B virus-related cirrhosis and overt hepatic encephalopathy (HBV-related OHE).We conducted an analysis of 1,404 participants diagnosed with HBV-related OHE between January 2008 and July 2023. The prognostic significance of the neutrophil-to-high-density lipoprotein cholesterol (HDL-C) ratio (NHR), lymphocyte-to-HDL-C ratio (LHR), and monocyte-to-2 HDL-C ratio (MHR) was evaluated using the area under the receiver operating characteristic curve (AUC). Restrictive cubic splines (RCS) were employed to explore the relationship between NHR and 12-month transplant-free (TF) mortality. This study included a prospective test cohort of 328 patients.Results: NHR was identified as an independent risk factor for 12-month TF mortality. The AUC for NHR (0.776) was similar to that of the model end-stage liver disease (MELD) score (AUC: 0.777).In the test cohort, NHR demonstrated AUC values comparable to MELD, with significantly higher AUCs than LHR and MHR (both P < 0.05). Based on cutoff values for NHR and MELD, patients were classified into four risk subgroups: very-low (NHR < 10 and MELD < 18), low (NHR ≥ 10 and MELD < 18), moderate (NHR < 10 and MELD ≥ 18), and high (NHR ≥ 10 and MELD ≥ 18). The 12-month TF mortality rates in the training cohort were 7.2%, 23.5%, 30.8%, and 51.4%, respectively, for these subgroups, while in the test cohort, the rates were 8.7%, 20.5%, 30.7%, and 46.0%.NHR is a valuable and accessible prognostic indicator for 12-month TF mortality in patients with HBV-related OHE. Patients with both NHR ≥ 10 and MELD ≥ 18 are at the highest risk of mortality.
Keywords: hepatitis B vir us, Hepatic Encephalopathy, model end-stage liver disease scor e, inflammator y, high density lipopr otein cholester ol
Received: 15 Nov 2024; Accepted: 08 Jan 2025.
Copyright: © 2025 Shi, Wang, Zhang, Li, Feng and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xiaojing Wang, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Yanqiu Li, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Ying Feng, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Xianbo Wang, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.